17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, discovery, modelling, synthesis, and biological evaluation of novel and small, low toxicity s-triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.

University of Tartu
Antiretroviral (HIV-1) activity of azulene derivatives.

University of Tartu
Fluorescent photoaffinity probes for mitotic protein kinase Aurora A.

University of Tartu
1-substituted apomorphines as potent dopamine agonists.

University of Tartu
Chemoenzymatic synthesis and evaluation of 3-azabicyclo[3.2.0]heptane derivatives as dopaminergic ligands.

University of Tartu
Conjugates of 5-isoquinolinesulfonylamides and oligo-D-arginine possess high affinity and selectivity towards Rho kinase (ROCK).

University of Tartu
New 2-thioether-substituted apomorphines as potent and selective dopamine D2 receptor agonists.

University of Tartu
Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases.

University of Tartu
N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.

University of Tartu
Carbocyclic 3'-deoxyadenosine-based highly potent bisubstrate-analog inhibitor of basophilic protein kinases.

University of Tartu
Construction of Covalent Bisubstrate Inhibitor of Protein Kinase Reacting with Cysteine Residue at Substrate-Binding Site.

University of Tartu
Indole-like Trk receptor antagonists.

University of Tartu
Thiazole- and selenazole-comprising high-affinity inhibitors possess bright microsecond-scale photoluminescence in complex with protein kinase CK2.

University of Tartu
Oligo-aspartic acid conjugates with benzo[c][2,6]naphthyridine-8-carboxylic acid scaffold as picomolar inhibitors of CK2.

University of Tartu
Aryl-benzocycloalkyl amide derivatives

Hoffmann-La Roche
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors.

Cyclacel
Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.

Emory University